Shirley M. Tsunoda Liver Transplant, Drug Metabolism/PK Research Interests Investigating the genetic and environmental factors that influence variability.

Slides:



Advertisements
Similar presentations
Pharmacological P-gp identification Since P-gp mediated drug efflux is a major hurdle in CNS drug discovery, it is important to identify P-gp substrates.
Advertisements

The Drug Discovery Process
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
Improving Candidate Quality Through the Prediction of Clinical Outcome.
PhD Student: NGUYEN Thi Van Anh Supervisor: Prof. Roselyne BOULIEU EA 4169 Department of Clinical Pharmacy Pharmacokinetics and Drug Evaluation Laboratory.
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner.
A General Overview The primary function of transporters is to transport endogenous substances, such as hormones, glucose, and amino acids; however, many.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Neonatal/Juvenile Animal Safety Studies Kenneth L. Hastings, Dr.P.H., D.A.B.T. Office of New Drugs, CDER.
Gastrointestinal Drugs Advisory Committee Meeting March 6, 2003 Drug Interactions of Aprepitant Venkat Jarugula, Ph.D. Clinical Pharmacology and Biopharmaceutics.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
Background: Focus on P-gp Questions:
Pharmacologic Principles Chapter 1, 2, 3. Understanding Nurses must understand both + and – effects of drugs Pharmacotherapeutics –u–use of drugs and.
Factors Affecting Drug Activity
Drug Metabolism Overview Dr. Arthur Roberts 1. Where to Find Information eLC – most up to date – correct errors 2.
Prof JH van Zyl Central role of liver in drug metabolism 02. Principal reactions in drug metabolism 03. Electron flow pathway in the microsomal.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Dose Prediction of Tacrolimus in de novo Kidney Transplant Patients with Population Pharmacokinetic Modelling Including Genetic Polymorphisms. R.R. Press.
Stefan Franzén Introduction to clinical trials.
Virtual Drug Development in Southern California, A Pre-Clinical Focus in vitro tests to support IND submissions David Johnson, Ph.D. Director, DMPK MicroConstants,
Clinical Pharmacy Part 2
Slide 1 EZT 2003-W SS Mechanism of Action and Pharmacology of Ezetimibe Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
Orientation to Pharmacology
Bill Gerwick Research Interests Characterizing the ‘weird and wonderful’ natural products of marine algae and cyanobacteria Drug discovery from marine.
Why do people use herbal drugs? Patient autonomy/control Ease of use Easy availability Confidentiality Possibility of fewer side effects (compared to.
Bioavailability Dr Mohammad Issa.
PHARMACOLOGY Searches for new drugs Investigates effects of known drugs WHAT IS PHARMACOLOGY ? pharmacologists are drug hunters mechanism of action, evidence.
Update: Topics Previously Presented to the CPSC Clinical Pharmacology Subcommittee (CPSC) of the Advisory Committee for Pharmaceutical Science November.
EFFECTS OF DULOXETINE ON THE PHARMACOKINETICS OF NEBIVOLOL IN HEALTHY VOLUNTEERS Corina Briciu 1, Maria Neag 2, Dana Muntean 3, Corina Bocsan 2, Anca Buzoianu.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical.
Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.
Clinical Pharmacokinetics of Carbamazepine
Phase I Issues for Novel TB Drugs Dakshina M. Chilukuri, Ph.D. Office of Clinical Pharmacology and Biopharmaceutics, FDA OPEN FORUM ON KEY ISSUES IN TB.
May 19, 2005FDA Antiviral Drugs Advisory Committee Meeting 1 Tipranavir NDA Drug Interactions Yuanchao (Derek) Zhang, Ph.D. Clinical Pharmacology.
Introduction to Hurel ISSX H µ REL ® C ORPORATION.
INTRODUCTION CLINICAL PHARMACOKINETICS
Introduction to the Meeting Introduction to the Meeting Advisory Committee for Pharmaceutical Sciences Clinical Pharmacology Subcommittee November 17-18,
Therapeutic drug Monitoring
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
CYP
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Joe Ma Research Interests: Drug Metabolism/PK and Pain Past: Examined and validated methods to evaluate drug-drug interaction/phenotyping studies (e.g.,
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
1 Transporters and Their Role in Drug Interactions.
PHT 415 BASIC PHARMACOKINETICS
Foundation Knowledge and Skills
Introduction Conclusions Liver transplant recipients with impaired renal function or a low dose-adjusted tacrolimus concentration suggesting a high CYP3A4.
Katharina Brandl Pharmacology, Educational Research Major instructional goals: Help students master new knowledge and skills Help students to not forget.
MCC - PI Guideline Pharmacological Action Pharmacodynamics –Describe mechanism of action (if known), pharmacodynamic effects, relevant clinical efficacy.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
Chapter 5 Drug Metabolism
FOOD-Drug Interactions (FDI)
Chapter 9 PHARMACOKINETICS VARIABILITY
Introduction of Biopharmaceutics & Pharmacokinetics
Pharmacokinetics.
Drug Elimination Drug elimination consists of 2 processes
Pharmacokinetics.
Understanding the Basics of Pharmacology
Recent Advancement In Therapeutics ZURAMPIC ( LESINURAD)
Pharmacokinetics and Drug Interactions in the new HCV Clinical Management SOC.
Conceptual Subdivisions of Pharmacology
Clinical Pharmacokinetics
Conceptual Subdivisions of Pharmacology
Pharmacogenomics Genes and Drugs.
Chapter 1 Introduction of Pharmacology [,fɑ:mə'kɔlədʒi] 药理学
Introduction to Pharmacogenetics
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Shirley M. Tsunoda Liver Transplant, Drug Metabolism/PK Research Interests Investigating the genetic and environmental factors that influence variability in immunosuppressive drug exposure and effect - genetic polymorphisms in drug metabolizing enzymes and transporters - environmental influences such as red wine, grapefruit juice, green tea, food - factors affecting intestinal integrity Understanding how intestinal and hepatic drug metabolizing enzymes and transporters affect bioavailability Understanding the interplay of uptake and efflux transporters and drug metabolizing enzymes in the intestine, liver, and kidney to the efficacy and safety of drugs

Core Expertise Clinical research in liver transplant patients Healthy volunteer pharmacokinetic studies Treatment of hepatitis C post-transplant Utilizing pharmacokinetics as a tool to understanding drug exposure, variability, mechanisms of drug-drug interactions Clinical pharmacology of CYP3A and P-gp substrates

Proposed Collaborations with SSPPS Faculty Collaborating with faculty who have analytical capability to measure drug and metabolite concentrations Collaborating with faculty with tools and systems to study intestinal and hepatic drug metabolism Pharmacokinetic studies of new compounds in healthy volunteers PK studies in transplant or liver disease patients Clinical pharmacology studies of drug-drug interactions